|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
21 November 2016 |
|
Main ID: |
NCT02175849 |
|
Date of registration:
|
25/06/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Intensifying Multi-Drug Resistant Tuberculosis Contact Tracing by Social Network Analysis
SNAP |
|
Scientific title:
|
Contact Tracing by Social Network Analysis to Enhance Multi-Drug Resistant Tuberculosis Case Finding in Hanoi, Vietnam |
|
Date of first enrolment:
|
December 2013 |
|
Target sample size:
|
596 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02175849 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Vietnam
| | | | | | | |
|
Contacts
|
|
Name:
|
Heiman F Wertheim, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Oxford University Clinical Research Unit - Hanoi |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- PATIENTS: Newly detected rifampicin resistant TB or MDR-TB patients living in Hanoi
for at least 3 months preceding a diagnosis made between 2013-2015.
- CONTACTS: During the 3 months before the patient's TB or MDR-TB diagnosis: all
persons who spend an average of >4 hours per day in the same residence as the patient
AND/OR any individual who has had frequent and prolonged contact with the patient
AND/OR anyone who has spent time in a closed environment with an MDR-TB patient
- PATIENTS AND CONTACTS: All ages
- PATIENTS AND CONTACTS: Living in Hanoi during the study period.
Exclusion Criteria:
-PATIENTS AND CONTACTS: Lack of informed consent for participation.
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Tuberculosis Infection
|
|
Primary Outcome(s)
|
|
Yield of MDR-TB case detection through SNA
[Time Frame: Six months]
|
|
Secondary Outcome(s)
|
|
MDR-TB incidence among subgroups of contacts
[Time Frame: Six months]
|
|
Cost-effectiveness ratio of SNA and passive case finding strategies
[Time Frame: Six months]
|
|
MDR-TB incidence among rifampicin resistant TB cases
[Time Frame: Six months]
|
|
MDR-TB genotype
[Time Frame: Six months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|